SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-163050
Filing Date
2024-06-18
Accepted
2024-06-18 07:45:05
Documents
40
Period of Report
2024-06-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d851091d8k.htm   iXBRL 8-K 28038
2 EX-99.1 d851091dex991.htm EX-99.1 45934
3 EX-99.2 d851091dex992.htm EX-99.2 43054
7 GRAPHIC g851091ex99_2s10g1.jpg GRAPHIC 144596
8 GRAPHIC g851091ex99_2s11g1.jpg GRAPHIC 168442
9 GRAPHIC g851091ex99_2s12g1.jpg GRAPHIC 91934
10 GRAPHIC g851091ex99_2s13g1.jpg GRAPHIC 120895
11 GRAPHIC g851091ex99_2s14g1.jpg GRAPHIC 141896
12 GRAPHIC g851091ex99_2s15g1.jpg GRAPHIC 160448
13 GRAPHIC g851091ex99_2s16g1.jpg GRAPHIC 137039
14 GRAPHIC g851091ex99_2s17g1.jpg GRAPHIC 149392
15 GRAPHIC g851091ex99_2s18g1.jpg GRAPHIC 133281
16 GRAPHIC g851091ex99_2s19g1.jpg GRAPHIC 152762
17 GRAPHIC g851091ex99_2s1g1.jpg GRAPHIC 57289
18 GRAPHIC g851091ex99_2s20g1.jpg GRAPHIC 152335
19 GRAPHIC g851091ex99_2s21g1.jpg GRAPHIC 53962
20 GRAPHIC g851091ex99_2s22g1.jpg GRAPHIC 23819
21 GRAPHIC g851091ex99_2s23g1.jpg GRAPHIC 30650
22 GRAPHIC g851091ex99_2s24g1.jpg GRAPHIC 23527
23 GRAPHIC g851091ex99_2s25g1.jpg GRAPHIC 154937
24 GRAPHIC g851091ex99_2s2g1.jpg GRAPHIC 227431
25 GRAPHIC g851091ex99_2s3g1.jpg GRAPHIC 111905
26 GRAPHIC g851091ex99_2s4g1.jpg GRAPHIC 115963
27 GRAPHIC g851091ex99_2s5g1.jpg GRAPHIC 145953
28 GRAPHIC g851091ex99_2s6g1.jpg GRAPHIC 102000
29 GRAPHIC g851091ex99_2s7g1.jpg GRAPHIC 126150
30 GRAPHIC g851091ex99_2s8g1.jpg GRAPHIC 154259
31 GRAPHIC g851091ex99_2s9g1.jpg GRAPHIC 162984
  Complete submission text file 0001193125-24-163050.txt   4464754

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tsha-20240618.xsd EX-101.SCH 2844
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsha-20240618_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsha-20240618_pre.xml EX-101.PRE 11703
43 EXTRACTED XBRL INSTANCE DOCUMENT d851091d8k_htm.xml XML 3767
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39536 | Film No.: 241050199
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)